This document is an excerpt from the EUR-Lex website
Document 31975L0319
National transposition measures communicated by the Member States concerning:
Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
OJ L 147, 09/06/1975, p. 13–22
(DA, DE, EN, FR, IT, NL) This document has been published in a special edition(s)
(EL, ES, PT, FI, SV)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Bekendtgørelse nr. 164 af 13/03/1995
Bekendtgorelse om bivirkningsovervagning af laegemidler ref: Bekendtgorelse n° 567 du 28/06/2002
Décision ministérielle numéro A6 9392/91 du 10/03/1992. FEK numéro 233 du 07/04/1992 Page 2258
Koninklijk Besluit van 08/09/1977, Staatsblad nummer 537 van 11/10/1977